Loading...
GEHC
XNAS
Market cap36bUSD
Nov 20, Last price  
80.64USD
1D
-1.53%
1Q
7.78%
IPO
33.31%
Name

GE Healthcare Technologies Inc

Chart & performance

D1W1MN
XNAS:GEHC chart
P/E
17.50
P/S
1.77
EPS
4.61
Vol. 1Y
35.82%
Shs. 5Y
0.24%
Rev. 5Y
3.74%
Div Yld LY
0.17%
Div Yld TTM
0.18%
Revenues
20.63b
+4.84%
16,633,000,00017,164,000,00017,585,000,00018,341,000,00019,552,000,00019,672,000,00020,625,000,000
Net income
2.08b
+4.57%
1,524,000,00013,846,000,0002,247,000,0001,916,000,0001,568,000,0001,993,000,0002,084,000,000
CFO
1.99b
+1.90%
1,989,000,0001,687,000,0001,607,000,0002,113,000,0002,101,000,0001,951,000,0001,988,000,000
Dividend
Oct 23, 20260.04 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Related entities

Subsidiaries (5)
GE HEALTHCARE (AB)
GE HEALTHCARE GLOBAL PRIVATE LIMITED
GE HEALTHCARE TRANSNATIONAL HOLDINGS, LLC
GE HEALTHCARE VIETNAM COMPANY LIMITED
BK MEDICAL ApS

Key people

H. Lawrence Culp
Chairman of the Board · since 2023
Peter Arduini
President, Chief Executive Officer, Director · since 2023
James Saccaro
Chief Financial Officer, Vice President · since 2023
Jeannette Bankes
Chief Executive Officer - Patient Care Solutions · since 2025
Kevin O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics · since 2023
Philip Rackliffe
President and CEO - Advanced Visualization Solutions · since 2025
Roland Rott
President and CEO - Imaging · since 2024
Adam Holton
Chief People Officer · since 2024
Taha Kass - Hout
Chief Science and Technology Officer · since 2023
Frank Jimenez
General Counsel, Corporate Secretary · since 2023
Kenneth Stacherski
Chief Global Supply Chain and Service Officer · since 2022
Lead Independent Director · since 2023
Rodney Hochman
Independent Director · since 2023
Catherine Lesjak
Independent Director · since 2022
Anne Madden
Independent Director · since 2023
Tomislav Mihaljevic
Independent Director · since 2023
William Stromberg
Independent Director · since 2023
Phoebe Yang
Independent Director · since 2023
IPO date
Dec 15, 2022
Employees
50,000
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
500 West Monroe Street
Chicago, IL 60661
US
Previous name
GE Healthcare Holding LLC

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT